On November 21, 2017 Exelixis, Inc. (NASDAQ: EXEL) reported that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide an overview of the company at the following two investor conferences in the coming weeks (Press release, Exelixis, NOV 21, 2017, View Source;p=RssLanding&cat=news&id=2318251 [SID1234522208]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 29th Annual Healthcare Conference: Exelixis’ presentation is scheduled for 11:00 AM EST / 8:00 AM PST on Tuesday, November 28, 2017 in New York, NY.

Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference: Exelixis’ presentation is scheduled for 12:05 PM EST / 9:05 AM PST on Wednesday, November 29, 2017 in Boston, MA.

To access the webcast link, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for 14 days.